AMANDA LARISCEY: Open Payments
NPI 1780164590 · VIDALIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 34 payments from 13 companies in 2025. Trend: 2023 $280 · 2024 $391 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Lilly USA, LLC | 4 | $84 |
| Inspire Medical Systems, Inc. | 3 | $67 |
| Novo Nordisk Inc | 3 | $56 |
| Corcept Therapeutics | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Dexcom, Inc. | 1 | $24 |
Products named: VRAYLAR, MOUNJARO, INSPIRE, Korlym, NEXLETOL, Wegovy, CAPLYTA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
